To examine trends in out-of-pocket costs for insulin among Medicare beneficiaries not receiving low-income subsidies.
Analyzed out-of-pocket costs for insulin from 2019 to 2023
Examined cost distribution by state
Focused on Medicare beneficiaries not receiving low-income subsidies
Out-of-pocket costs for insulin decreased over the study period
Cost distribution varied significantly by state
Findings suggest improved affordability of insulin for some beneficiaries
Abstract
This study reports decreasing out-of-pocket costs for insulin among Medicare beneficiaries not receiving the low-income subsidy and examines the distribution of costs by state from 2019 through 2023.